David M Eddy

Summary

Publications

  1. ncbi request reprint Archimedes: a trial-validated model of diabetes
    David M Eddy
    Kaiser Permanente Southern California, Pasadena, California, USA
    Diabetes Care 26:3093-101. 2003
  2. ncbi request reprint Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes
    David M Eddy
    Archimedes Project, Kaiser Permanente, Oakland, California, USA
    Ann Intern Med 143:251-64. 2005
  3. ncbi request reprint Archimedes: a new model for simulating health care systems--the mathematical formulation
    Leonard Schlessinger
    Department of Biomathematical Analysis, Care Management Institute, Kaiser Permanente Program Office, Pasadena, CA, USA
    J Biomed Inform 35:37-50. 2002
  4. ncbi request reprint Evidence-based medicine: a unified approach
    David M Eddy
    Health Aff (Millwood) 24:9-17. 2005
  5. ncbi request reprint Linking electronic medical records to large-scale simulation models: can we put rapid learning on turbo?
    David M Eddy
    Archimedes Inc, San Francisco, CA, USA
    Health Aff (Millwood) 26:w125-36. 2007
  6. doi request reprint The 'Global Outcomes Score': a quality measure, based on health outcomes, that compares current care to a target level of care
    David M Eddy
    Archimedes, San Francisco, California, USA
    Health Aff (Millwood) 31:2441-50. 2012
  7. doi request reprint A simulation shows limited savings from meeting quality targets under the Medicare Shared Savings Program
    David M Eddy
    Archimedes, San Francisco, California, USA
    Health Aff (Millwood) 31:2554-62. 2012
  8. ncbi request reprint Accuracy versus transparency in pharmacoeconomic modelling: finding the right balance
    David M Eddy
    Archimedes, Inc, San Francisco, California, USA
    Pharmacoeconomics 24:837-44. 2006
  9. ncbi request reprint Validation of the archimedes diabetes model
    David M Eddy
    Care Management Institute, Kaiser Permanente and Kaiser Permanente Southern California, Oakland, California, USA
    Diabetes Care 26:3102-10. 2003
  10. ncbi request reprint Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7
    David M Eddy
    Archimedes, Inc, San Francisco, CA 94105, USA
    Med Decis Making 32:733-43. 2012

Collaborators

Detail Information

Publications15

  1. ncbi request reprint Archimedes: a trial-validated model of diabetes
    David M Eddy
    Kaiser Permanente Southern California, Pasadena, California, USA
    Diabetes Care 26:3093-101. 2003
    ..To build a mathematical model of the anatomy, pathophysiology, tests, treatments, and outcomes pertaining to diabetes that could be applied to a wide variety of clinical and administrative problems and that could be validated...
  2. ncbi request reprint Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes
    David M Eddy
    Archimedes Project, Kaiser Permanente, Oakland, California, USA
    Ann Intern Med 143:251-64. 2005
    ..Lifestyle modification can forestall diabetes in high-risk people, but the long-term cost-effectiveness is uncertain...
  3. ncbi request reprint Archimedes: a new model for simulating health care systems--the mathematical formulation
    Leonard Schlessinger
    Department of Biomathematical Analysis, Care Management Institute, Kaiser Permanente Program Office, Pasadena, CA, USA
    J Biomed Inform 35:37-50. 2002
    ..Although Archimedes was originally designed for health care applications, the formulation, and equations are general and can be applied to many natural systems...
  4. ncbi request reprint Evidence-based medicine: a unified approach
    David M Eddy
    Health Aff (Millwood) 24:9-17. 2005
    ..This paper describes the problem that we are asking "evidence" to solve and the different methods by which evidence can be used to help solve that problem, and recommends a unified approach...
  5. ncbi request reprint Linking electronic medical records to large-scale simulation models: can we put rapid learning on turbo?
    David M Eddy
    Archimedes Inc, San Francisco, CA, USA
    Health Aff (Millwood) 26:w125-36. 2007
    ..Linking the models to EMR data also facilitates tailoring analyses to specific populations. The models' power and accuracy can be improved by linkage to comprehensive, person-specific, longitudinal data from EMRs...
  6. doi request reprint The 'Global Outcomes Score': a quality measure, based on health outcomes, that compares current care to a target level of care
    David M Eddy
    Archimedes, San Francisco, California, USA
    Health Aff (Millwood) 31:2441-50. 2012
    ..The GO Score can be used to assess the potential effectiveness of different interventions such as prevention activities, tests, and treatments...
  7. doi request reprint A simulation shows limited savings from meeting quality targets under the Medicare Shared Savings Program
    David M Eddy
    Archimedes, San Francisco, California, USA
    Health Aff (Millwood) 31:2554-62. 2012
    ..To achieve greater savings, accountable care organizations will have to lower costs by other means, such as through improved use of information technology and care coordination...
  8. ncbi request reprint Accuracy versus transparency in pharmacoeconomic modelling: finding the right balance
    David M Eddy
    Archimedes, Inc, San Francisco, California, USA
    Pharmacoeconomics 24:837-44. 2006
    ..Rigorous simulations of clinical trials are a good place to start. This is the type of empirical validation we need to provide if the potential of mathematical models in pharmacoeconomics is to be fully achieved...
  9. ncbi request reprint Validation of the archimedes diabetes model
    David M Eddy
    Care Management Institute, Kaiser Permanente and Kaiser Permanente Southern California, Oakland, California, USA
    Diabetes Care 26:3102-10. 2003
    ..To validate the Archimedes model of diabetes and its complications for a variety of populations, organ systems, treatments, and outcomes...
  10. ncbi request reprint Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7
    David M Eddy
    Archimedes, Inc, San Francisco, CA 94105, USA
    Med Decis Making 32:733-43. 2012
    ....
  11. doi request reprint The potential effects of HEDIS performance measures on the quality of care
    David M Eddy
    Archimedes Inc, San Francisco, California, USA
    Health Aff (Millwood) 27:1429-41. 2008
    ..1 million cases of end-stage renal disease (17 percent). If performance had been 100 percent, 1.4 million more MIs would have been prevented. Control of blood pressure has the largest potential effect on quality at the national level...
  12. doi request reprint Individualized guidelines: the potential for increasing quality and reducing costs
    David M Eddy
    Archimedes, 201 Mission Street, San Francisco, CA 91405, USA
    Ann Intern Med 154:627-34. 2011
    ..Current guidelines focus on a particular risk factor and specify criteria for categorizing persons into a small number of treatment groups...
  13. ncbi request reprint Diabetes Risk Calculator: a simple tool for detecting undiagnosed diabetes and pre-diabetes
    Kenneth E Heikes
    Archimedes, San Francisco, California, USA
    Diabetes Care 31:1040-5. 2008
    ..The objective of this study was to develop a simple tool for the U.S. population to calculate the probability that an individual has either undiagnosed diabetes or pre-diabetes...
  14. doi request reprint Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--7
    David M Eddy
    Archimedes, Inc, San Francisco, CA, USA
    Value Health 15:843-50. 2012
    ....
  15. doi request reprint Effect of smoking cessation advice on cardiovascular disease
    David M Eddy
    Archimedes, Inc, San Francisco, California, USA
    Am J Med Qual 24:241-9. 2009
    ..The 30-year cost/QALY is approximately $3000 less than the base-case assumptions and less than $10 000 under pessimistic assumptions...